Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
other: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
2013
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2013
Report date:
2013

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Fatty acids, coco derivs., reaction products with glycine, potassium salts
EC Number:
620-582-5
Cas Number:
301341-58-2
Molecular formula:
R-CO-NH-CH2-COOK (Note: "R-CO-" is a fatty acid residue)
IUPAC Name:
Fatty acids, coco derivs., reaction products with glycine, potassium salts
Specific details on test material used for the study:
Lot/batch No.: 110825
Expiration date: August 25, 2014
Purity: 100%

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
Test animals: Crl:WI (Charles River, Germany)

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Doses:
2000 mg/kg
No. of animals per sex per dose:
2 * 3 rats
Control animals:
no

Results and discussion

Effect levels
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
no
Clinical signs:
0.5 - 4 hrs after dosing piloerection was noted in all 6 rats. In addition, all 6 rats showed a hunched posture 2 hrs after dosing. 6 hrs after dosing and from days 1-14 all rats were free of any abnormalities.
Body weight:
No adverse effects observed
Gross pathology:
No adverse effects observed

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria
Conclusions:
The oral LD50 is > 2000 mg/kg bw
Executive summary:

The acute oral toxicity of the test item was examined in female Wistar rats in a study according to OECD Guideline 423 with GLP compliance. Apart from piloerection and hunched posture seen 0.5 - 4 hrs after dosing no other adverse effects were reported. The oral LD50 was > 2000 mg/kg bw.